3rd Quarter - Report

CAPITOL HILL CONSULTING GROUP for ELI LILLY AND COMPANY

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

general healthcare issues related to pharmaceutical and biological products; Federal, Food, Drug and Cosmetic Act (21 USC 9); Public Health Service Act (42 USC 6A); Follow-on Biologics; Comparative Effectiveness; Comparative Effectiveness Research Act (S.3408); Enhanced Health Care Value for All Act (HR2184); Promoting Innovation and Access to Life-saving Medicine Act (HR1427/S.726); Biologics Price Competition and Innovation Act of 2007 (S.1695); Pathway for Biosimilars Acr (HR1548); Health Reform; America's Affordable Health Choices Act (HR3200); America's Healthy Future Act

LobbyistCovered position, as disclosed
BILL K BREWSTER —
STEVEN E IRIZARRY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1695 (111th), H.R. 2184 (111th), H.R. 1427 (111th), S. 3408 (111th), H.R. 1548 (111th), H.R. 3200 (111th), S. 726 (111th)

Medicare/Medicaid MMM

general Medicare and Medicaid issues, including but not limited to, coverage and reimbursement; America's Affordable Health Choices Act (HR3200); America's Healthy Future Act

LobbyistCovered position, as disclosed
BILL K BREWSTER —
STEVEN E IRIZARRY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3200 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.